Recursion Pharmaceuticals is trading 4.38% up at $4.30, with no fresh company-specific announcement or clear catalyst identified for the October 5 move.
- Major U.S. indexes were near flat or uneven during the session.
- Reports described cautious trading amid rising yields and uncertainty.
- Friday’s rally followed weaker-than-expected jobs data, but that does not establish a direct cause for this morning’s move.